Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026

Stock Information for Adaptimmune Ther

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Adaptimmune Ther

Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
Vaxart to Host Upcoming Conference Calls
Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
Vaxart to Host Upcoming Conference Calls
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.